NCT06795412
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06795412
Title Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pyxis Oncology, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of California San Diego RECRUITING San Diego California 92093 United States Details
Sarcoma Oncology Center RECRUITING Santa Monica California 90403 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
University of Pennsylvania RECRUITING Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh Medical Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
University of Texas - M.D. Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology Houston RECRUITING Houston Texas 77054 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
Hospital Universitario Vall d'Hebron RECRUITING Barcelona Barcelona 08035 Spain Details
Hospital Universitario Ramón y Cajal RECRUITING Madrid Madrid 28034 Spain Details
START Madrid - Hospital Universitario Fundación Jiménez Díaz RECRUITING Madrid Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre RECRUITING Madrid Madrid 28041 Spain Details
Hospital Clínico Universitario de Valencia RECRUITING Valencia València 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field